Venmax Drugs and Pharmaceuticals Limited (BOM:531015)

BOM:531015 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	24.82	0.03	0	0	0.75
Cash & Short-Term Investments	24.82	0.03	0	0	0.75
Cash Growth	99196.00%	733.33%	-	-99.60%	5485.27%
Accounts Receivable	-	-	0.36	0.36	0.36
Other Receivables	9.53	-	-	-	1.04
Receivables	9.53	-	0.36	0.36	1.4
Inventory	0.58	-	-	-	-
Other Current Assets	16.37	0.13	1.02	0.96	0.02
Total Current Assets	51.29	0.16	1.38	1.33	2.17
Property, Plant & Equipment	0.41	0.45	0.5	0.56	0.62
Other Intangible Assets	-	0.21	0.23	0.26	0.28
Other Long-Term Assets	-0	-	-	-	0
Total Assets	51.7	0.81	2.11	2.14	3.08
Accounts Payable	6.29	1.03	3.29	4.71	4.65
Accrued Expenses	-	1.13	1.7	-	0.49
Short-Term Debt	0.5	3.52	3.52	3.49	23.29
Current Income Taxes Payable	-	0.22	-	-	-
Other Current Liabilities	0.78	1.36	0.7	3.3	2.47
Total Current Liabilities	7.57	7.27	9.21	11.49	30.9
Long-Term Deferred Tax Liabilities	0.01	0.05	0.05	0.05	0.04
Other Long-Term Liabilities	-	-	-	-	-0
Total Liabilities	7.58	7.32	9.26	11.54	30.94
Common Stock	52.39	52.39	52.39	52.39	52.39
Additional Paid-In Capital	-	-	-	7.3	7.3
Retained Earnings	-	-58.89	-59.53	-69.09	-87.56
Comprehensive Income & Other	-8.27	-	-	-	-
Shareholders' Equity	44.12	-6.5	-7.15	-9.4	-27.86
Total Liabilities & Equity	51.7	0.81	2.11	2.14	3.08
Total Debt	0.5	3.52	3.52	3.49	23.29
Net Cash (Debt)	24.33	-3.5	-3.52	-3.49	-22.54
Net Cash Per Share	4.63	-0.67	-0.67	-0.67	-4.30
Filing Date Shares Outstanding	5.24	5.24	5.24	5.24	5.24
Total Common Shares Outstanding	5.24	5.24	5.24	5.24	5.24
Working Capital	43.73	-7.11	-7.83	-10.17	-28.72
Book Value Per Share	8.42	-1.24	-1.36	-1.79	-5.32
Tangible Book Value	44.12	-6.71	-7.38	-9.66	-28.14
Tangible Book Value Per Share	8.42	-1.28	-1.41	-1.84	-5.37
Machinery	-	-	-	0.62	0.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.